1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
BTB Korea Co.,Ltd

BTB Korea Co.,Ltd

KKRX:219750
2,750.00
KRW
+40.00
(+1.48%)
-609.81EPS
27.86BMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
59,896.02
116,248.16
120,477.27
92,723.46
108,520.44
56,921.65
31,201.14
13,357.78
6,223.85
2,813.24
2,444.02
2,058.77
Basic EPS, GAAP
1,280.5
7,343.77
10,837.57
-24,583.83
-18,432.39
-55,826.3
-30,117.98
-30,115.15
-21,279.34
-15
-300
-609.81
Free Cash Flow per Basic Share
-20,480.88
-27,354.88
-14,972.34
-26,183.99
-58,062.95
-36,611.95
-35,586.46
2,593.89
-5,270.83
-122.33
-486.34
-459.37
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
23,478.7
31,022.97
56,032.89
71,521.87
52,877.89
30,892.96
28,870.39
7,376.06
407.76
2,158.52
1,857.95
1,510.83
Tangible Book Value per Share
21,908.1
26,910.58
42,992.48
62,524.07
43,448.07
26,148.25
27,281.09
7,091.75
346.99
2,050.84
1,740.27
1,398.85
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
11
13
13
Sales/Revenue/Turnover
10,735
21,335
24,046
21,507
30,274
17,160
13,269
5,670
2,698
30,135
32,031
26,920
Operating Margin (%)
8.29
8.52
8.48
-14.33
-15.16
-51.72
-90.67
-134.23
-273.69
3.28
-8.58
-19.96
Depreciation Expense
150
332
548
891
1,332
1,305
1,419
925
562
679
725
776
Net Income, GAAP
229
1,348
2,163
-5,702
-5,142
-16,830
-12,808
-12,783
-9,226
-161
-3,932
-7,974
Effective Tax Rate (%)
2.93
4.28
14.52
- -
- -
- -
- -
- -
- -
614.7
- -
- -
Profit Margin (%)
2.14
6.32
9
-26.51
-16.99
-98.08
-96.53
-225.45
-341.9
-0.53
-12.27
-29.62
Working Capital
6,456
11,794
12,178
11,810
2,366
-2,895
-14,465
-25,923
-14,731
4,612
10,908
-2,532
LT Debt
3,479
10,861
7,338
451
7,512
10,241
6,680
326
71
4,763
13,170
3,127
Total Equity
4,309
5,694
12,275
19,678
14,548
10,260
11,298
3,166
409
28,235
24,303
19,763
Return on Invested Capital (%)
- -
12.03
8.3
- -
- -
- -
- -
- -
- -
-26.98
- -
- -
Return on Capital (%)
- -
15.67
14.19
- -
- -
- -
- -
- -
- -
-14.2
- -
- -
Return on Common Equity (%)
- -
26.95
24.72
-36.22
-30.05
-135.68
-118.83
-176.75
-516.11
-1.12
-14.97
-33.57

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
217
6,221
10,197
LT Borrowings
13,000
7,000
3,000
LT Finance Leases
170
158
127
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
56,443
62,264
27,862

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
17,680
15,867
14,093
Cash, Cash Equivalents & STI
6,592
4,692
3,544
Accounts Receivable, Net
4,839
4,674
4,579
Inventories
3,196
3,975
5,136
Total Current Liabilities
6,772
12,731
16,624
Payables & Accruals
- -
- -
- -
ST Debt
217
6,221
10,197
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
679.27%
1,328.04%
-13.92%
Free Cash Flow
20.04%
-6.8%
386.4%
Net Income, GAAP
259.84%
439.35%
2,346.94%
Sales/Revenue/Turnover
98.91%
178.15%
6.29%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6,194
6,779
7,122
- -
30,135
2025
10,023
7,307
7,699
7,002
32,031
2026
5,911
6,309
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
36.39
-83.04
-1.53
- -
-15
2025
4.26
-295
-64.68
-198.06
-300
2026
-128.16
-219
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Wan-Kyu Choi
Full Time Employees
100
Sector
Health technology
Industry
Medical specialties
Address
Seongnam-si South Korea
IPO Date
Jun 17, 2015
Website
btbkorea.kr
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
BTB Korea Co.,Ltd. is a South Korea-based company primarily engaged in the development, manufacture, and distribution of medical aesthetic equipment, personal beauty care devices, and life science research products. Founded in 1999 and headquartered in Seongnam-si, Gyeonggi-do, South Korea, the company operates across two core business segments: the Medical Device Division and the Biotechnology Division. Its comprehensive product and service portfolio includes professional medical aesthetic and dermatology systems, featuring the Picoholic picosecond laser platform, the Leshape non-invasive body contouring diode laser, and the Dual Hi high-intensity focused ultrasound (HIFU) skin lifting system; personal home aesthetic devices marketed under the LEBODY brand, comprising microcurrent body sculpting devices, facial toning equipment, and LED therapy masks; and biotechnology supplies, including molecular biology research reagents, diagnostic assay kits, cell culture media, specialized antibodies, and laboratory analytical consumables supplied to universities, research institutes, hospitals, and pharmaceutical enterprises. The company operates as a subsidiary of BNC KOREA, Inc., serving both domestic and international markets across Asia, Europe, and the Americas. In recent corporate developments, the company executed a major strategic restructuring and rebranding, changing its name from GTG Wellness Co., Ltd. to BTB Korea Co.,Ltd. in 2024 following the acquisition of controlling interest by parent company BNC KOREA, Inc., alongside the strategic absorption merger of Dongin Biotech Co., Ltd. to expand its business portfolio into life science distribution and biotechnology research solutions.